I will give you some thought on the contract so far, based on my experience. I have been lucky because the DM in my district has been really great and doesn't get irrational or unreasonable. I am getting a new DM due to the expansion and hope it goes well. The response to an old cheap product being revisited and brought to modern day safety standards is very mixed. Some doctors will appreciate the new safety data and some will tell you to go blow and get out of the office. If a doctor has 20 patients who get the medication for a decent price and 1 patient who doesn't, watch out. The doctor may throw out all positive experience for one negative.
The last bonus was very generous and was based some on performance and some on market clearance. URL gave reps with low historical use of colchicine a conversion factor option which paid out nicely. The next bonus plan won't be as generous and will be based on your territory performance because conversion will be over.
The biggest issue is cost. The new information on colchicine is useful and puts a good medication back into use.
Hope that helps.